Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Albumedix
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
12.0%
+2.8% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:NeutralThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Merck KGaA
Competitor Displacement Rate
15.0%
Competitors are displacing Albumedix in 15.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Albumedix's specialized protein-based drug delivery systems are highly regarded, but large pharmaceutical companies like Merck KGaA are investing heavily in competing technologies, potentially displacing niche players.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[merckgroup.com][lifecore.com]⚠️ Identified Vulnerability:Platform Technology
Primary Threat Identified:Merck KGaA
Target Persona:Pharmaceutical R&D departments
🚨 Threat Velocity:6/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)